scholarly journals TCT-731 Transcatheter Aortic Valve Replacement versus Surgical Valve Replacement for low to intermediate surgical-risk patients: A meta-analysis of 5,346 patients

2016 ◽  
Vol 68 (18) ◽  
pp. B295-B296
Author(s):  
Aakash Garg ◽  
Abhishek Sharma ◽  
Sahil Agrawal ◽  
Deepti Virmani ◽  
John Kostis ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Meta Analysis ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
Risk Patients ◽  
Surgical Valve Replacement

Meta-Analysis of Transcatheter Aortic Valve Replacement in Low-Risk Patients

2020 ◽  
Vol 133 (2) ◽  
pp. e38-e41 ◽  
Author(s):  
Babikir Kheiri ◽  
Mohammed Osman ◽  
Ahmed Bakhit ◽  
Qais Radaideh ◽  
Mahmoud Barbarawi ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Meta Analysis ◽  
Low Risk ◽  
Transcatheter Aortic Valve ◽  
Risk Patients

scholarly journals Transcatheter Aortic Valve Replacement in Young Low-Risk Patients With Severe Aortic Stenosis: A Review

2020 ◽  
Vol 7 ◽  
Author(s):  
Pier Paolo Bocchino ◽  
Filippo Angelini ◽  
Brunilda Alushi ◽  
Federico Conrotto ◽  
Giacomo Maria Cioffi ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Severe Aortic Stenosis ◽  
Low Risk ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
Risk Patients

In the last decades, transcatheter aortic valve replacement (TAVR) revolutionized the treatment of symptomatic severe aortic stenosis. The efficacy and safety of TAVR were first proven in inoperable and high-risk patients. Then, subsequent randomized clinical trials showed non-inferiority of TAVR as compared to surgical aortic valve replacement also in intermediate- and low-risk populations. As TAVR was progressively studied and clinically used in lower-risk patients, issues were raised questioning its opportunity in a younger population with a longer life-expectancy. As long-term follow-up data mainly derive from old studies with early generation devices on high or intermediate surgical risk patients, results can hardly be extended to most of currently treated patients who often show a low surgical risk and are treated with newer generation prostheses. Thus, in this low-risk younger population, decision making is difficult due to the lack of supporting data. The aim of the present review is to revise current literature regarding TAVR in younger patients.

Sign in / Sign up

Export Citation Format

Share Document